IMPACT OF COVID-19 CARONAVIRUS ON POVERTY IN PAKISTAN: A CASE STUDY OF SINDH

DR. Faiz Muhammad Shaikh; Ali Raza Memon; Kashaf Shaikh

doi:10.31149/ijefsd.v2i4.411

Authors

DR. Faiz Muhammad Shaikh
[email protected]
Associate Professor-SZABAC-Dokri
Ali Raza Memon Ph.D Scholar in Istanbul, Turkey
Kashaf Shaikh Student of MBA-SZABIST-Larkana

Vol. 2 No. 4 (2020): APRIL

Articles

June 29, 2020

Downloads

pdf

Abstract
How to Cite
Metrics
References

The current research investigated the COVID-19 is spread
vigorously in China, USA, France, Italy, Germany, and
European countries and Iran Pakistan being as a neighbor
country of china & Iran One was for the incoming Pakistani
from various countries, such as Iran, China, Afghanistan, and
India. The other was arranged inside various hospitals for
COVID-19 positive cases. As hundreds and thousands of
Pakistani were in Iran for religious purposes, they were. Most
of the students and businessmen, inside China, were not
allowed to come back. Handling of large scale influx from Iran
was the main problem. Out of the total COVID-19 cases, 78
percent of cases were reported from visitors coming from Iran.
Pakistan announced the closure of all schools, colleges &
universities with a partial lockdown across the country for
major cities

DR. Faiz Muhammad Shaikh, Ali Raza Memon, & Kashaf Shaikh. (2020). IMPACT OF COVID-19 CARONAVIRUS ON POVERTY IN PAKISTAN: A CASE STUDY OF SINDH. International Journal on Economics, Finance and Sustainable Development, 2(4), 5–16. https://doi.org/10.31149/ijefsd.v2i4.411

Download Citation

 European Centre for Disease Prevention and Control data. Geographical distribution of 2019- nCov cases. Available online:(https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases) (accessed on 05 February 2020)
 World Health Organization, 2019- nCoV Situation Report-22 on 12 February 2020.https://www.who.int/docs/defaultsource/coronavirus/situation-reports/
 Gralinski L, Menachery V. Return of the Coronavirus: 2019- nCoV, Viruses 2020;12:135. [CrossRef ]
 Chen Z, Zhang W, Lu Y, et al. From SARS-CoV to Wuhan 2019- nCoV Outbreak: Similarity of Early Epidemic and Prediction of FutureTrends: Cell Press 2020. [CrossRef ]
 Luk HK, Li X, Fung J, Lau SK, Woo PC. Molecular epidemiology, evolution, and phylogeny of SARS coronavirus. Infection, Genetics andEvolution 2019;71:21–30. [CrossRef ]
 Coronavirinae in ViralZone. Available online: https://viralzone. expasy.org/785 (accessed on 05 February 2019).
 Subissi L, Posthuma CC, Collet A, Zevenhoven-Dobbe JC, Gorbalenya AE, Decroly E, et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc Natl Acad Sci USA 2014;111:E3900–E3909. [CrossRef ]
 Lambeir AM, Durinx C, Scharpe S, De Meester I. Dipeptidyl- peptidase IV from bench to bedside: An update on structural properties,functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003;40:209–94. [CrossRef]
 Chu H, Zhou J, Wong BH, Li C, Cheng ZS, Lin X, et al. Productive replication of Middle East respiratory syndrome coronavirus in monocytederived dendritic cells modulates the innate immune response. Virology 2014;454–455:197–205. [CrossRef ]
 Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis. J Infect Dis 2014;209:1331–42.[CrossRef ]
 Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proceedings of the Society for Experimental Biology andMedicine 1966;121:190–3. [CrossRef ]
 Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to globalhealth -The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;264–6. [CrossRef ]
 Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States TheNew England Journal of Medicine 2020. [CrossRef ]
 WHO. Emergencies preparedness, response. Pneumonia of unknown origin – China. Disease outbreak news. Available online: https://HYPERLINK "http://www.who.int/csr/don/12- January-2020-novel-coronavirus-china/en/" www.who.int/ csr/don/12-January-2020-novelcoronavirus-china/en/ (accessed on 05 February 2020)
 Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany, 30.01.2020. [CrossRef ]
 Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020, published online Jan 29, https://doi.org/10.1016/ S0140-6736(20)30211-7.
 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; published online Jan 24. HYPERLINK "https://doi. org/10.1016/S01406736(20)301835" https://doi.org/10.1016/
 Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N England J Medicine, Publish online Jan 29. DOI: 10.1056/NEJMoa2001017 [CrossRef ]
 Wang C, Horby PW, Harden FG, Gao GF. A novel coronavirüs outbreak of global health concern. Lancet 2020, publish on- lined Jan 24, https://doi.org/10.1016/S0140-6736(20)30185-9.
 Arabi YM, Alothman A, Balkhy, et al. Treatment of the Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 2016;19;81. [CrossRef ]